| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10956355 | Molecular and Cellular Endocrinology | 2011 | 10 Pages |
Abstract
The present review briefly summarizes the current knowledge but will be focussed on the ligand-dependency of EGFR transactivation. Several alternative mechanisms and novel aspects will be introduced. Using the example of head and neck squamous carcinoma, the potency of EGFR transactivation as a therapeutical target will be discussed.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Claus Liebmann,